![](/img/cover-not-exists.png)
An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes
Goldberg, Stuart L., Fenaux, Pierre, Craig, Michael D., Gyan, Emmanuel, Lister, John, Kassis, Jeannine, Pigneux, Arnaud, Schiller, Gary J., Jung, JungAh, Jane Leonard, E., Fingert, Howard, Westervelt,Volume:
3
Year:
2014
Language:
english
Journal:
Leukemia Research Reports
DOI:
10.1016/j.lrr.2014.06.003
File:
PDF, 329 KB
english, 2014